Study boosts NMT's bioabsorbable heart repair implant
This article was originally published in Clinica
Executive Summary
NMT Medical is stepping up efforts to gain European market approval for its BioSTAR bioabsorbable implant for closing septal defects in the heart, after the device yielded positive six-month follow-up data in a clinical trial.